Fabio Prati

ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 4

Top Topics

Mass Spectrometry

Diffusion Weighted

Acinetobacter Baumannii

Structure Activity Relationship

Top Venues

Antimicrobial agents and chemotherapy

ACS infectious diseases

Journal of medicinal chemistry

Organic & biomolecular chemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Andrew R Mack, Vijay Kumar, Magdalena A Taracila, María Fernanda Mojica, Margaret O'Shea, William Schinabeck, Galen Silver, Andrea M Hujer, Krisztina M Papp-Wallace, Shuang Chen, Shozeb M Haider, Emilia Caselli, Fabio Prati, Focco van den Akker, Robert A Bonomo
Natural protein engineering in the Ω-loop: the role of Y221 in ceftazidime and ceftolozane resistance in Pseudomonas -derived cephalosporinase. Antimicrobial agents and chemotherapy (2023)
Rachel A Powers, Cynthia M June, Micah C Fernando, Erin R Fish, Olivia L Maurer, Rachelle M Baumann, Trevor J Beardsley, Magdalena A Taracila, Susan D Rudin, Kristine M Hujer, Andrea M Hujer, Nicolo Santi, Valentina Villamil, Maria Luisa Introvigne, Fabio Prati, Emilia Caselli, Robert A Bonomo, Bradley J Wallar
Synthesis of a Novel Boronic Acid Transition State Inhibitor, MB076: A Heterocyclic Triazole Effectively Inhibits Acinetobacter -Derived Cephalosporinase Variants with an Expanded-Substrate Spectrum. Journal of medicinal chemistry (2023)
Francesco Fini, Alessandro Zanni, Maria Luisa Introvigne, Mattia Stucchi, Emilia Caselli, Fabio Prati
Straightforward synthesis of chiral non-racemic α-boryl isocyanides. Organic & biomolecular chemistry 19 (30) (2022)
Emilia Caselli, Francesco Fini, Maria Luisa Introvigne, Mattia Stucchi, Magdalena A Taracila, Erin R Fish, Kali A Smolen, Philip N Rather, Rachel A Powers, Bradley J Wallar, Robert A Bonomo, Fabio Prati
1,2,3-Triazolylmethaneboronate: A Structure Activity Relationship Study of a Class of β-Lactamase Inhibitors against Acinetobacter baumannii Cephalosporinase. ACS infectious diseases 6 (7) (2020)